The measurement of cognitive function during acute hypoglycaemia: Experimental limitations and their effect on the study of hypoglycaemia unawareness

Diabetic Medicine

Volumn 13, Issue 7, 1996, Pages 607-615

  Heller, S R ^a   Macdonald, I A ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cognitive function; Hypoglycaemia unawareness; Type 1 diabetes

Indexed keywords

BRAIN FUNCTION; COGNITION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

ATTENTION; BRAIN; COGNITION; COGNITION DISORDERS; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, VISUAL; HUMANS; HYPOGLYCEMIA; MEMORY; PERCEPTION;

EID: 0030035377     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199607)13:7<607::AID-DIA159>3.0.CO;2-I     Document Type: Review

References (72)

1. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabetic Med 1991; 8: 217-222.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes 1993; 42: 1549-1554.
4. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90: 450-459.
5. Wredling RAM, Levander S, Adamson U, Lins PE. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 1990; 33: 152-157.
6. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 1991, 34: 337-344.
7. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 1993; 42: 341-344.
8. Reichard P, Britz A, Rosenquist U. Intensified conventional insulin treatment and neuropsychological impairment. Br Med J 1991; 303: 1439-1442.
9. Biessels GJ, Kapelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia 1994; 37: 643-650.
10. Gold AE, Deary IJ, Frier BM. Recurrent severe hypoglycaemia and cognitive function in Type 1 diabetes. Diabetic Med 1994; 10: 503-508.
11. Banting FG, Campbell WR, Fletcher AA. Further clinical experience with insulin (pancreatic extract) in the treatment of diabetes mellitus. Br Med J 1923; 1: 8-12.
12. Russell PN, Rix-Trot HM. An exploratory study of some behavioural consequences of insulin induced hypoglycaemia. NZ Med J 1975; 81: 337-340.
13. Holmes CS, Hayford JT, Gonzalez JL, Weydert JA. A survey of different functioning at different glucose levels in diabetic persons. Diabetes Care 1983; 6: 180-185.
14. Pramming S, Thorsteinsson B, Theilgard A, Pinner EM, Binder C. Cognitive function during hypoglycaemia in Type 1 diabetes mellitus. Br Med J 1986; 292: 647-650.
15. De Fronzo R, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 273: E214-E223.
16. Heller SR, Macdonald IA, Herbert M, Tattersall RB. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet 1987; ii: 359-363.
17. Amiel SA, Simonson DC, Tamborlane WV, Defronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987; 36: 518-522.
18. Kerr D, Macdonald IA, Tattersall RB. Patients with type 1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabetic Med 1991; 8: 123-128.
19. McCall AL. Effects of glucose deprivation on glucose metabolism in the central nervous system. In: Frier BM, Fisher BM, eds. Hypoglycaemia and Diabetes. London: Edward Arnold, 1993; 56-71.
20. McCall AL. Brain endothelium expresses insulin responsive glucose transporters. (Abstract) Diabetes 1992; 41: 153A.
21. Foster KJ, Alberti KGMM, Hinks L, Lloyd B, Postle A, Smythe P, et al. Blood intermediary and metabolite concentrations after an overnight fast: reference ranges for adults and interrelations. Clin Chem 1978; 24: 1568-1572.
22. Hampton SM, Mogan LM, Tredgar JA, Cramb R, Marks V. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion. Diabetes 1986, 35: 612-616.
23. Liu D, Moberg E, Kollind ME, Lins PE, Adamson UKC, Macdonald IA. Arterial, arterialized-venous, venous and capillary blood glucose measurements during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992; 35: 287-290.
24. McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976; 41: 565-573.
25. Deary IJ. Effects of hypoglycaemia on cognitive function. In: Frier BM, Fisher BM, eds. Hypoglycaemia and Diabetes. London: Edward Arnold, 1993; 80-92.
26. Stevens AB, McKane WR, Bell PM, Bell P, King DJ, Hayes JR. Psychomotor performance and counterregulatory responses during mild hypoglycemia in healthy volunteers. Diabetes Care 1989; 12: 12-17.
27. Holmes CS, Koepke KM, Thompson RG. Simple versus complex impairments at three blood glucose levels. Psychoneuroendocrinology 1986; 11: 353-357.
28. Hoffman RG, Speelman DJ, Hinnen DA, Conley KL, Guthrie RA, Knapp RK. Changes in cortical functioning with acute hypoglycemia and hyperglycemia in Type 1 diabetes. Diabetes Care 1989; 12: 193-197.
29. Wilkinson RT, Houghton D. Portable four-choice reaction time test with magnetic tape memory. Behav Res Methods Instrumentation 1975; 7: 441-446.
30. Herald KC, Polonsky KS, Cohen RM, Levy J, Douglas F. Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes 1985; 34: 677-685.
31. Mitrakou A, Ryan CM, Veneman T, Mokan M, Jenssen T, Kiss I, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 1991; 260: E67-E74.
32. Wirsen A, Tallroth G, Lindgren M, Agardh C. Neuropsychological performance differs between type 1 diabetic and normal men during insulin-induced hypoglycaemia. Diabetic Med 1992; 9: 156-165.
33. Blackman JD, Towle VL, Lewis GF, Spire J, Polonsky KS. Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes 1990; 39: 828-835.
34. Snorgaard O, Lassen LH, Rosenfalck AM, Binder C. Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counter-regulatory hormones in subjects with functional hypoglycaemia. J Intern Med 1991; 229: 343-350.
35. Holmes CS. Metabolic control and auditory information processing at altered glucose levels in insulin-dependent diabetes. Brain and Cognition 1987; 6: 161-174.
36. Ryan CM, Atchinson J, Puczynski S, Puczynski M, Arslanian S, Becker D. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediat 1990; 117: 32-38.
37. Widom B, Simonson DC. Glycemic control and neuropsychological function during hypoglycemia in patients with IDDM. Ann Intern Med 1990; 112: 904-912.
38. Ryan CM. Measures of cognitive function. In: Bradley C, ed. Handbook of Psychology and Diabetes. Chur: Harwood, 1994; 191-222.
39. Boyle PJ, Nagy RJ, O'Connor AM, Kempers SF, Yeo RA, Qualls C. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 1994; 91: 9352-9356.
40. Holmes CS, Koepke KM, Thompson RG, Gyves PW, Weydert JA. Verbal fluency and naming performance in Type 1 diabetes at different blood glucose concentrations. Diabetes Care 1984; 7: 454-459.
41. Freyschuss U, Hjemdahl P, Juhlin-Dannfelt A, Linde B. Cardiovascular and sympathoadrenal responses to mental stress: influence of beta-blockade. Am J Physiol 1988; 255: H1443-H1451.
42. Harrad RA, Cockram CS, Plumb AP, Stone S, Fenwick P, Sonksen PH. The effect of hypoglycaemia on visual function: a clinical and electrophysiological study. Clin Sci 1985; 69: 673-679.
43. Duncan-Johnson CC, Donchin E. The P300 component of the event-related brain potential as an index of information processing. Biol Psych 1982; 14: 1-52.
44. DeFeo P, Gallai V, Mazzotta G, Crispino G, Torlone E, Perriello G, et al. Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 1988; 82: 436-444.
45. Jones TW, McCarthy G, Tamborlane WV, Caprio S, Roessler E, Kraemer D, et al. Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes 1990; 39: 1550-1555.
46. King P, Parkin H, Macdonald IA, Barber C, Tattersall RB. Intravenous lactate protects cerebral function during hypoglycaemia. (Astract) Diabetologia 1995; 38: A203.
47. Gonder-Frederick LA, Cox DJ, Driesen NR, Ryan CM, Clarke WL. Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes 1994; 43: 1407-1412.
48. Herbert M. The duration of post-anaesthetic mental impairment. In: Hindmarch I, Jones JG, Moss E, eds. Aspects of Recovery from Anaesthesia. London: John Wiley, 1987; 103-112.
49. Herbert M. Assessment of performance in studies of anaesthetic agents. Br J Anaesth 1978; 50: 33-38.
50. Scott WAC, Whitwam JG, Wilkinson RT. Choice reaction time: a method of measuring postoperative performance decrements. Anaesthesia 1983; 38: 1162-1168.
51. Gold AE, Deary IJ, MacLeod KM, Frier BM. The effect of IQ level on the degree of cognitive deterioration experienced during acute hypoglycaemia in normal humans. Intelligence 1995; 20: 267-290.
52. Kerr D, Macdonald IA, Tattersall RB. Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counterregulatory hormones. Diabetologia 1989; 32: 249-254.
53. Gold AE, Deary IJ, MacLeod KM, Thomson KJ, Frier BM. Cognitive function during insulin-induced hypoglycemia in humans: short-term cerebral adaptation does not occur. Psychopharmacology 1995; 119: 325-333.
54. Cox DJ, Gonder-Frederick LA, Clarke WL. Driving decrements in type 1 diabetes during moderate hypoglycemia. Diabetes 1993; 42: 239-243.
55. Cryer PE, Binder C, Bolli GB, Cherrington AD, Gale EAM, Gerich JE, et al. Hypoglycemia in insulin dependent diabetes mellitus. Diabetes 1989; 38: 1193-1199.
56. Heller SR, Macdonald IA. Physiological disturbances in hypoglycaemia: effect on subjective awareness. Clin Sci 1991; 81: 1-9.
57. Towler DA, Havlin CE, Craft S, Cryer PE. Mechanism of awareness of hypoglycemia: Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791-1798.
58. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993; 36: 771-777.
59. Kerr D, Macdonald IA, Heller SR, Tattersall RB, Alcohol intoxication causes hypoglycaemia unawareness in healthy volunteers and patients with Type 1 (insulin-dependent) diabetes. Diabetologia 1990; 33: 216-221.
60. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 (insulin dependent) diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
61. Cryer PE. Hypoglycemia unawareness in IDDM. Diabetes Care 1994; 16: 40-47.
62. Hoeldtke RD, Boden G, Shuman CR, Owen OE. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 1982; 96: 459-462.
63. Grimaldi A, Bosquet F, Davidoff P, Digy JP, Sachon C, Landault C, et al. Unawareness of hypoglycemia by insulin-dependent diabetics. Horm Metab Res 1990; 22: 90-95.
64. Clarke WL, Gonder-Frederick LA, Richards FE, Cryer PE. Multifactorial origin of hypoglycemic symptom awareness in insulin dependent diabetes mellitus. Diabetes 1991; 40: 680-685.
65. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 1995; 38: 1412-1418.
66. Amiel SA. Limits of normality: the mechanisms of hypoglycaemia unawareness. Diabetic Med 1994; 11: 918-924.
67. Cranston I, Lomas J, Maran A, Macdonald IA, Amiel SA. Restoration of hypoglycaemia unawareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283-287.
68. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42: 1683-1689.
69. Jones TW, McCarthy G, Tamborlane WV, Roessler E, Sherwin RS. Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetes (Abstract). Diabetes 1991; 40: 557A.
70. Ziegler D, Hubinger A, Muhler A, Gries FA. Effect of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in type 1 insulin dependent diabetic patients. Diabetologia 1992; 35: 828-834.
71. Heller SR, Chapman J, McCloud J, Ward JD. Unreliability of reports of hypoglycaemia by diabetic patients. Br Med J 1995; 310: 440.
72. Kerr D, Diamond MP, Tamborlane WV, Kerr S, Sherwin RS. Influence of counterregulatory hormones independently of hypoglycaemia on cognitive function, warning symptoms and glucose kinetics. Clin Sci 1993; 85: 197-202.